Abstract

Recent data suggest that post-ischemic brain neurodegeneration in humans and animals is associated with the modified tau protein in a manner typical of Alzheimer’s disease neuropathology. Pathological changes in the tau protein, at the gene and protein level due to cerebral ischemia, can lead to the development of Alzheimer’s disease-type neuropathology and dementia. Some studies have shown increased tau protein staining and gene expression in neurons following ischemia-reperfusion brain injury. Recent studies have found the tau protein to be associated with oxidative stress, apoptosis, autophagy, excitotoxicity, neuroinflammation, blood-brain barrier permeability, mitochondrial dysfunction, and impaired neuronal function. In this review, we discuss the interrelationship of these phenomena with post-ischemic changes in the tau protein in the brain. The tau protein may be at the intersection of many pathological mechanisms due to severe neuropathological changes in the brain following ischemia. The data indicate that an episode of cerebral ischemia activates the damage and death of neurons in the hippocampus in a tau protein-dependent manner, thus determining a novel and important mechanism for the survival and/or death of neuronal cells following ischemia. In this review, we update our understanding of proteomic and genomic changes in the tau protein in post-ischemic brain injury and present the relationship between the modified tau protein and post-ischemic neuropathology and present a positive correlation between the modified tau protein and a post-ischemic neuropathology that has characteristics of Alzheimer’s disease-type neurodegeneration.

Highlights

  • A dangerous consequence of an ischemic episode to the brain is the massive death of neurons with the progressive occurrence of neurodegeneration and the development of full-blown dementia [1,2,3,4,5,6]

  • We described the neuropathological role of the tau protein after brain ischemia

  • The presented data demonstrate that the tau protein plays a very important role, in the stabilization and structure of microtubules, and in the neuropathology of the brain after ischemia (Figure 1)

Read more

Summary

Introduction

A dangerous consequence of an ischemic episode to the brain is the massive death of neurons with the progressive occurrence of neurodegeneration and the development of full-blown dementia [1,2,3,4,5,6]. It has been suggested that ischemic brain injury in humans and animals is associated with the successive incidence of Alzheimer’s disease-type neuropathology [35]. We discuss the post-ischemic mechanisms related to the genotype and phenotype of Alzheimer’s disease, which interconnect the emergence of the increased expression of the tau protein gene and its modified products. This is due to the emergence of a large amount of new evidence for genomic and proteomic changes in the tau protein in humans and animals after cerebral ischemia. We will look at possible future treatment strategies to slow or reduce neuropathological responses following brain ischemia associated with tau protein modifications

Post-Ischemic Tau Protein Gene Expression in the Brain
Post-Ischemic Tau Protein Accumulation in the Brain
Post-Ischemic Tau Protein in the Blood after Brain Injury
Post-Ischemic Tau Protein Hyperphosphorylation in the Brain
Post-Ischemic Tau Protein and Neurofibrillary Tangle Development in the Brain
Post‐Ischemia
Post-Ischemic
Post-Ischemic Tau Protein versus Mitochondria
Post-Ischemic Tau Protein versus Autophagy
Post-Ischemic Tau Protein versus Apoptosis
Post-Ischemic Tau Protein versus Neuroinflammation
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call